Unexpected consequences of proton pump inhibitor use

Area of Science:

• Gastroenterology and Otolaryngology
• Pharmacology of acid-related disorders

Background:

• Proton pump inhibitors (PPIs) are frequently prescribed for gastroesophageal and laryngopharyngeal reflux.
• Emerging evidence suggests laryngeal disease involves pepsin and acidic microenvironments, not solely acid reflux.
• Widespread PPI use necessitates evaluating potential adverse effects.

Purpose of the Study:

• To discuss potential unexpected complications associated with proton pump inhibitor (PPI) therapy.
• To highlight the role of pepsin and acidic microenvironments in laryngeal mucosal disease.
• To consider optimal patient management strategies in light of PPI use and potential consequences.

Main Methods:

• This is a commentary, not an experimental study.
• Review of existing literature on PPIs, reflux disease, and laryngeal pathology.
• Discussion of emerging evidence and clinical implications.

Main Results:

• The pathogenesis of laryngeal mucosal disease may involve factors beyond acid reflux, such as pepsin.
• The extensive use of PPIs raises concerns about potential unforeseen complications.
• A nuanced approach to patient management is required.

Conclusions:

• Further investigation into the mechanisms of reflux-related laryngeal disease is warranted.
• The long-term safety and efficacy of PPIs require ongoing evaluation.
• Personalized patient management considering both benefits and risks of PPIs is crucial.